PRQR
PRQR
NASDAQ · Biotechnology

Proqr Therapeutics Nv

$1.65
+0.00 (+0.00%)
As of Sep 28, 10:17 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +457.6% upside
Low Target $6.27
Average Target $9.20
High Target $10.38
Current Price $1.65
Current
$1.65
Target
$9.20
$6.27 $9.20 avg $10.38
Scenario Analysis
Bear Case
$6.27
280.0%
Low target
Base Case
$9.20
+457.6%
Avg target
Bull Case
$10.38
+529.1%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$3.10
-46.8% from high
52-Week Low
$1.33
+24.1% from low
Target vs 52W High
$9.20
+196.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%